Global Liver Cancer Diagnostics Market Insights, Forecast to 2029
This report presents an overview of global market for Liver Cancer Diagnostics market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Liver Cancer Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liver Cancer Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liver Cancer Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Liver Cancer Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Liver Cancer Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, BD, Roche Holding AG, Fujifilm Healthcare, Hologic, Illumina, Philips, Oncimmune and Qiagen, etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Liver Cancer Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Cancer Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver Cancer Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
This report researches the key producers of Liver Cancer Diagnostics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Liver Cancer Diagnostics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liver Cancer Diagnostics revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Liver Cancer Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Liver Cancer Diagnostics revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott Laboratories, BD, Roche Holding AG, Fujifilm Healthcare, Hologic, Illumina, Philips, Oncimmune and Qiagen, etc.
By Company
- Abbott Laboratories
- BD
- Roche Holding AG
- Fujifilm Healthcare
- Hologic
- Illumina
- Philips
- Oncimmune
- Qiagen
- Siemens Healthineers
- Sirtex Medical
- Biopsy
- Endoscopy
- Laboratory Tests
- Imaging
- Others
- Hospital
- Clinic
- Laboratory
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East, Africa, and Latin America
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Liver Cancer Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Cancer Diagnostics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liver Cancer Diagnostics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Cancer Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Biopsy
1.2.3 Endoscopy
1.2.4 Laboratory Tests
1.2.5 Imaging
1.2.6 Others
1.3 Market by Application
1.3.1 Global Liver Cancer Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Liver Cancer Diagnostics Market Perspective (2018-2029)
2.2 Global Liver Cancer Diagnostics Growth Trends by Region
2.2.1 Liver Cancer Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Liver Cancer Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Liver Cancer Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Liver Cancer Diagnostics Market Dynamics
2.3.1 Liver Cancer Diagnostics Industry Trends
2.3.2 Liver Cancer Diagnostics Market Drivers
2.3.3 Liver Cancer Diagnostics Market Challenges
2.3.4 Liver Cancer Diagnostics Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Liver Cancer Diagnostics by Players
3.1.1 Global Liver Cancer Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Liver Cancer Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Liver Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Liver Cancer Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Liver Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Liver Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Cancer Diagnostics Revenue in 2022
3.5 Global Key Players of Liver Cancer Diagnostics Head office and Area Served
3.6 Global Key Players of Liver Cancer Diagnostics, Product and Application
3.7 Global Key Players of Liver Cancer Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 LIVER CANCER DIAGNOSTICS BREAKDOWN DATA BY TYPE
4.1 Global Liver Cancer Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Liver Cancer Diagnostics Forecasted Market Size by Type (2024-2029)
5 LIVER CANCER DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
5.1 Global Liver Cancer Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Liver Cancer Diagnostics Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Liver Cancer Diagnostics Market Size (2018-2029)
6.2 North America Liver Cancer Diagnostics Market Size by Type
6.2.1 North America Liver Cancer Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Liver Cancer Diagnostics Market Size by Type (2024-2029)
6.2.3 North America Liver Cancer Diagnostics Market Share by Type (2018-2029)
6.3 North America Liver Cancer Diagnostics Market Size by Application
6.3.1 North America Liver Cancer Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Liver Cancer Diagnostics Market Size by Application (2024-2029)
6.3.3 North America Liver Cancer Diagnostics Market Share by Application (2018-2029)
6.4 North America Liver Cancer Diagnostics Market Size by Country
6.4.1 North America Liver Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Liver Cancer Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Liver Cancer Diagnostics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Liver Cancer Diagnostics Market Size (2018-2029)
7.2 Europe Liver Cancer Diagnostics Market Size by Type
7.2.1 Europe Liver Cancer Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Liver Cancer Diagnostics Market Size by Type (2024-2029)
7.2.3 Europe Liver Cancer Diagnostics Market Share by Type (2018-2029)
7.3 Europe Liver Cancer Diagnostics Market Size by Application
7.3.1 Europe Liver Cancer Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Liver Cancer Diagnostics Market Size by Application (2024-2029)
7.3.3 Europe Liver Cancer Diagnostics Market Share by Application (2018-2029)
7.4 Europe Liver Cancer Diagnostics Market Size by Country
7.4.1 Europe Liver Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Liver Cancer Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Liver Cancer Diagnostics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Liver Cancer Diagnostics Market Size (2018-2029)
8.2 China Liver Cancer Diagnostics Market Size by Type
8.2.1 China Liver Cancer Diagnostics Market Size by Type (2018-2023)
8.2.2 China Liver Cancer Diagnostics Market Size by Type (2024-2029)
8.2.3 China Liver Cancer Diagnostics Market Share by Type (2018-2029)
8.3 China Liver Cancer Diagnostics Market Size by Application
8.3.1 China Liver Cancer Diagnostics Market Size by Application (2018-2023)
8.3.2 China Liver Cancer Diagnostics Market Size by Application (2024-2029)
8.3.3 China Liver Cancer Diagnostics Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Liver Cancer Diagnostics Market Size (2018-2029)
9.2 Asia Liver Cancer Diagnostics Market Size by Type
9.2.1 Asia Liver Cancer Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Liver Cancer Diagnostics Market Size by Type (2024-2029)
9.2.3 Asia Liver Cancer Diagnostics Market Share by Type (2018-2029)
9.3 Asia Liver Cancer Diagnostics Market Size by Application
9.3.1 Asia Liver Cancer Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Liver Cancer Diagnostics Market Size by Application (2024-2029)
9.3.3 Asia Liver Cancer Diagnostics Market Share by Application (2018-2029)
9.4 Asia Liver Cancer Diagnostics Market Size by Region
9.4.1 Asia Liver Cancer Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Liver Cancer Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Liver Cancer Diagnostics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Liver Cancer Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.1.5 Abbott Laboratories Recent Developments
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Liver Cancer Diagnostics Introduction
11.2.4 BD Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.2.5 BD Recent Developments
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Details
11.3.2 Roche Holding AG Business Overview
11.3.3 Roche Holding AG Liver Cancer Diagnostics Introduction
11.3.4 Roche Holding AG Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.3.5 Roche Holding AG Recent Developments
11.4 Fujifilm Healthcare
11.4.1 Fujifilm Healthcare Company Details
11.4.2 Fujifilm Healthcare Business Overview
11.4.3 Fujifilm Healthcare Liver Cancer Diagnostics Introduction
11.4.4 Fujifilm Healthcare Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.4.5 Fujifilm Healthcare Recent Developments
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic Liver Cancer Diagnostics Introduction
11.5.4 Hologic Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.5.5 Hologic Recent Developments
11.6 Illumina
11.6.1 Illumina Company Details
11.6.2 Illumina Business Overview
11.6.3 Illumina Liver Cancer Diagnostics Introduction
11.6.4 Illumina Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.6.5 Illumina Recent Developments
11.7 Philips
11.7.1 Philips Company Details
11.7.2 Philips Business Overview
11.7.3 Philips Liver Cancer Diagnostics Introduction
11.7.4 Philips Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.7.5 Philips Recent Developments
11.8 Oncimmune
11.8.1 Oncimmune Company Details
11.8.2 Oncimmune Business Overview
11.8.3 Oncimmune Liver Cancer Diagnostics Introduction
11.8.4 Oncimmune Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.8.5 Oncimmune Recent Developments
11.9 Qiagen
11.9.1 Qiagen Company Details
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Liver Cancer Diagnostics Introduction
11.9.4 Qiagen Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.9.5 Qiagen Recent Developments
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Details
11.10.2 Siemens Healthineers Business Overview
11.10.3 Siemens Healthineers Liver Cancer Diagnostics Introduction
11.10.4 Siemens Healthineers Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.10.5 Siemens Healthineers Recent Developments
11.11 Sirtex Medical
11.11.1 Sirtex Medical Company Details
11.11.2 Sirtex Medical Business Overview
11.11.3 Sirtex Medical Liver Cancer Diagnostics Introduction
11.11.4 Sirtex Medical Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.11.5 Sirtex Medical Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Cancer Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Biopsy
1.2.3 Endoscopy
1.2.4 Laboratory Tests
1.2.5 Imaging
1.2.6 Others
1.3 Market by Application
1.3.1 Global Liver Cancer Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Liver Cancer Diagnostics Market Perspective (2018-2029)
2.2 Global Liver Cancer Diagnostics Growth Trends by Region
2.2.1 Liver Cancer Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Liver Cancer Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 Liver Cancer Diagnostics Forecasted Market Size by Region (2024-2029)
2.3 Liver Cancer Diagnostics Market Dynamics
2.3.1 Liver Cancer Diagnostics Industry Trends
2.3.2 Liver Cancer Diagnostics Market Drivers
2.3.3 Liver Cancer Diagnostics Market Challenges
2.3.4 Liver Cancer Diagnostics Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Revenue Liver Cancer Diagnostics by Players
3.1.1 Global Liver Cancer Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Liver Cancer Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Liver Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Liver Cancer Diagnostics, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Liver Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Liver Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Cancer Diagnostics Revenue in 2022
3.5 Global Key Players of Liver Cancer Diagnostics Head office and Area Served
3.6 Global Key Players of Liver Cancer Diagnostics, Product and Application
3.7 Global Key Players of Liver Cancer Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 LIVER CANCER DIAGNOSTICS BREAKDOWN DATA BY TYPE
4.1 Global Liver Cancer Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global Liver Cancer Diagnostics Forecasted Market Size by Type (2024-2029)
5 LIVER CANCER DIAGNOSTICS BREAKDOWN DATA BY APPLICATION
5.1 Global Liver Cancer Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global Liver Cancer Diagnostics Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Liver Cancer Diagnostics Market Size (2018-2029)
6.2 North America Liver Cancer Diagnostics Market Size by Type
6.2.1 North America Liver Cancer Diagnostics Market Size by Type (2018-2023)
6.2.2 North America Liver Cancer Diagnostics Market Size by Type (2024-2029)
6.2.3 North America Liver Cancer Diagnostics Market Share by Type (2018-2029)
6.3 North America Liver Cancer Diagnostics Market Size by Application
6.3.1 North America Liver Cancer Diagnostics Market Size by Application (2018-2023)
6.3.2 North America Liver Cancer Diagnostics Market Size by Application (2024-2029)
6.3.3 North America Liver Cancer Diagnostics Market Share by Application (2018-2029)
6.4 North America Liver Cancer Diagnostics Market Size by Country
6.4.1 North America Liver Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Liver Cancer Diagnostics Market Size by Country (2018-2023)
6.4.3 North America Liver Cancer Diagnostics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 EUROPE
7.1 Europe Liver Cancer Diagnostics Market Size (2018-2029)
7.2 Europe Liver Cancer Diagnostics Market Size by Type
7.2.1 Europe Liver Cancer Diagnostics Market Size by Type (2018-2023)
7.2.2 Europe Liver Cancer Diagnostics Market Size by Type (2024-2029)
7.2.3 Europe Liver Cancer Diagnostics Market Share by Type (2018-2029)
7.3 Europe Liver Cancer Diagnostics Market Size by Application
7.3.1 Europe Liver Cancer Diagnostics Market Size by Application (2018-2023)
7.3.2 Europe Liver Cancer Diagnostics Market Size by Application (2024-2029)
7.3.3 Europe Liver Cancer Diagnostics Market Share by Application (2018-2029)
7.4 Europe Liver Cancer Diagnostics Market Size by Country
7.4.1 Europe Liver Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Liver Cancer Diagnostics Market Size by Country (2018-2023)
7.4.3 Europe Liver Cancer Diagnostics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 CHINA
8.1 China Liver Cancer Diagnostics Market Size (2018-2029)
8.2 China Liver Cancer Diagnostics Market Size by Type
8.2.1 China Liver Cancer Diagnostics Market Size by Type (2018-2023)
8.2.2 China Liver Cancer Diagnostics Market Size by Type (2024-2029)
8.2.3 China Liver Cancer Diagnostics Market Share by Type (2018-2029)
8.3 China Liver Cancer Diagnostics Market Size by Application
8.3.1 China Liver Cancer Diagnostics Market Size by Application (2018-2023)
8.3.2 China Liver Cancer Diagnostics Market Size by Application (2024-2029)
8.3.3 China Liver Cancer Diagnostics Market Share by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Liver Cancer Diagnostics Market Size (2018-2029)
9.2 Asia Liver Cancer Diagnostics Market Size by Type
9.2.1 Asia Liver Cancer Diagnostics Market Size by Type (2018-2023)
9.2.2 Asia Liver Cancer Diagnostics Market Size by Type (2024-2029)
9.2.3 Asia Liver Cancer Diagnostics Market Share by Type (2018-2029)
9.3 Asia Liver Cancer Diagnostics Market Size by Application
9.3.1 Asia Liver Cancer Diagnostics Market Size by Application (2018-2023)
9.3.2 Asia Liver Cancer Diagnostics Market Size by Application (2024-2029)
9.3.3 Asia Liver Cancer Diagnostics Market Share by Application (2018-2029)
9.4 Asia Liver Cancer Diagnostics Market Size by Region
9.4.1 Asia Liver Cancer Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Liver Cancer Diagnostics Market Size by Region (2018-2023)
9.4.3 Asia Liver Cancer Diagnostics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 MIDDLE EAST, AFRICA, AND LATIN AMERICA
10.1 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 KEY PLAYERS PROFILES
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Liver Cancer Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.1.5 Abbott Laboratories Recent Developments
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Liver Cancer Diagnostics Introduction
11.2.4 BD Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.2.5 BD Recent Developments
11.3 Roche Holding AG
11.3.1 Roche Holding AG Company Details
11.3.2 Roche Holding AG Business Overview
11.3.3 Roche Holding AG Liver Cancer Diagnostics Introduction
11.3.4 Roche Holding AG Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.3.5 Roche Holding AG Recent Developments
11.4 Fujifilm Healthcare
11.4.1 Fujifilm Healthcare Company Details
11.4.2 Fujifilm Healthcare Business Overview
11.4.3 Fujifilm Healthcare Liver Cancer Diagnostics Introduction
11.4.4 Fujifilm Healthcare Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.4.5 Fujifilm Healthcare Recent Developments
11.5 Hologic
11.5.1 Hologic Company Details
11.5.2 Hologic Business Overview
11.5.3 Hologic Liver Cancer Diagnostics Introduction
11.5.4 Hologic Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.5.5 Hologic Recent Developments
11.6 Illumina
11.6.1 Illumina Company Details
11.6.2 Illumina Business Overview
11.6.3 Illumina Liver Cancer Diagnostics Introduction
11.6.4 Illumina Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.6.5 Illumina Recent Developments
11.7 Philips
11.7.1 Philips Company Details
11.7.2 Philips Business Overview
11.7.3 Philips Liver Cancer Diagnostics Introduction
11.7.4 Philips Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.7.5 Philips Recent Developments
11.8 Oncimmune
11.8.1 Oncimmune Company Details
11.8.2 Oncimmune Business Overview
11.8.3 Oncimmune Liver Cancer Diagnostics Introduction
11.8.4 Oncimmune Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.8.5 Oncimmune Recent Developments
11.9 Qiagen
11.9.1 Qiagen Company Details
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Liver Cancer Diagnostics Introduction
11.9.4 Qiagen Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.9.5 Qiagen Recent Developments
11.10 Siemens Healthineers
11.10.1 Siemens Healthineers Company Details
11.10.2 Siemens Healthineers Business Overview
11.10.3 Siemens Healthineers Liver Cancer Diagnostics Introduction
11.10.4 Siemens Healthineers Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.10.5 Siemens Healthineers Recent Developments
11.11 Sirtex Medical
11.11.1 Sirtex Medical Company Details
11.11.2 Sirtex Medical Business Overview
11.11.3 Sirtex Medical Liver Cancer Diagnostics Introduction
11.11.4 Sirtex Medical Revenue in Liver Cancer Diagnostics Business (2018-2023)
11.11.5 Sirtex Medical Recent Developments
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global Liver Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Biopsy
Table 3. Key Players of Endoscopy
Table 4. Key Players of Laboratory Tests
Table 5. Key Players of Imaging
Table 6. Key Players of Others
Table 7. Global Liver Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Liver Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Liver Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Liver Cancer Diagnostics Market Share by Region (2018-2023)
Table 11. Global Liver Cancer Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Liver Cancer Diagnostics Market Share by Region (2024-2029)
Table 13. Liver Cancer Diagnostics Market Trends
Table 14. Liver Cancer Diagnostics Market Drivers
Table 15. Liver Cancer Diagnostics Market Challenges
Table 16. Liver Cancer Diagnostics Market Restraints
Table 17. Global Liver Cancer Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Liver Cancer Diagnostics Revenue Share by Players (2018-2023)
Table 19. Global Top Liver Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Diagnostics as of 2022)
Table 20. Global Liver Cancer Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Liver Cancer Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Liver Cancer Diagnostics, Headquarters and Area Served
Table 23. Global Key Players of Liver Cancer Diagnostics, Product and Application
Table 24. Global Key Players of Liver Cancer Diagnostics, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Liver Cancer Diagnostics Revenue Market Share by Type (2018-2023)
Table 28. Global Liver Cancer Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Liver Cancer Diagnostics Revenue Market Share by Type (2024-2029)
Table 30. Global Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Liver Cancer Diagnostics Revenue Share by Application (2018-2023)
Table 32. Global Liver Cancer Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Liver Cancer Diagnostics Revenue Share by Application (2024-2029)
Table 34. North America Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Liver Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Liver Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Liver Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Liver Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Liver Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Liver Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Liver Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Liver Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Liver Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Liver Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Liver Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Liver Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Liver Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Liver Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Liver Cancer Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Liver Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Liver Cancer Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Liver Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Liver Cancer Diagnostics Product
Table 69. Abbott Laboratories Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 70. Abbott Laboratories Recent Developments
Table 71. BD Company Details
Table 72. BD Business Overview
Table 73. BD Liver Cancer Diagnostics Product
Table 74. BD Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 75. BD Recent Developments
Table 76. Roche Holding AG Company Details
Table 77. Roche Holding AG Business Overview
Table 78. Roche Holding AG Liver Cancer Diagnostics Product
Table 79. Roche Holding AG Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 80. Roche Holding AG Recent Developments
Table 81. Fujifilm Healthcare Company Details
Table 82. Fujifilm Healthcare Business Overview
Table 83. Fujifilm Healthcare Liver Cancer Diagnostics Product
Table 84. Fujifilm Healthcare Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 85. Fujifilm Healthcare Recent Developments
Table 86. Hologic Company Details
Table 87. Hologic Business Overview
Table 88. Hologic Liver Cancer Diagnostics Product
Table 89. Hologic Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 90. Hologic Recent Developments
Table 91. Illumina Company Details
Table 92. Illumina Business Overview
Table 93. Illumina Liver Cancer Diagnostics Product
Table 94. Illumina Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 95. Illumina Recent Developments
Table 96. Philips Company Details
Table 97. Philips Business Overview
Table 98. Philips Liver Cancer Diagnostics Product
Table 99. Philips Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 100. Philips Recent Developments
Table 101. Oncimmune Company Details
Table 102. Oncimmune Business Overview
Table 103. Oncimmune Liver Cancer Diagnostics Product
Table 104. Oncimmune Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 105. Oncimmune Recent Developments
Table 106. Qiagen Company Details
Table 107. Qiagen Business Overview
Table 108. Qiagen Liver Cancer Diagnostics Product
Table 109. Qiagen Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 110. Qiagen Recent Developments
Table 111. Siemens Healthineers Company Details
Table 112. Siemens Healthineers Business Overview
Table 113. Siemens Healthineers Liver Cancer Diagnostics Product
Table 114. Siemens Healthineers Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 115. Siemens Healthineers Recent Developments
Table 116. Sirtex Medical Company Details
Table 117. Sirtex Medical Business Overview
Table 118. Sirtex Medical Liver Cancer Diagnostics Product
Table 119. Sirtex Medical Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 120. Sirtex Medical Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 1. Global Liver Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Biopsy
Table 3. Key Players of Endoscopy
Table 4. Key Players of Laboratory Tests
Table 5. Key Players of Imaging
Table 6. Key Players of Others
Table 7. Global Liver Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 8. Global Liver Cancer Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global Liver Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Liver Cancer Diagnostics Market Share by Region (2018-2023)
Table 11. Global Liver Cancer Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global Liver Cancer Diagnostics Market Share by Region (2024-2029)
Table 13. Liver Cancer Diagnostics Market Trends
Table 14. Liver Cancer Diagnostics Market Drivers
Table 15. Liver Cancer Diagnostics Market Challenges
Table 16. Liver Cancer Diagnostics Market Restraints
Table 17. Global Liver Cancer Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Liver Cancer Diagnostics Revenue Share by Players (2018-2023)
Table 19. Global Top Liver Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Diagnostics as of 2022)
Table 20. Global Liver Cancer Diagnostics Industry Ranking 2021 VS 2022 VS 2023
Table 21. Global 5 Largest Players Market Share by Liver Cancer Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Global Key Players of Liver Cancer Diagnostics, Headquarters and Area Served
Table 23. Global Key Players of Liver Cancer Diagnostics, Product and Application
Table 24. Global Key Players of Liver Cancer Diagnostics, Product and Application
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Liver Cancer Diagnostics Revenue Market Share by Type (2018-2023)
Table 28. Global Liver Cancer Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global Liver Cancer Diagnostics Revenue Market Share by Type (2024-2029)
Table 30. Global Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Liver Cancer Diagnostics Revenue Share by Application (2018-2023)
Table 32. Global Liver Cancer Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global Liver Cancer Diagnostics Revenue Share by Application (2024-2029)
Table 34. North America Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 35. North America Liver Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 36. North America Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 37. North America Liver Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 38. North America Liver Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 39. North America Liver Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 40. North America Liver Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 41. Europe Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 42. Europe Liver Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 43. Europe Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 44. Europe Liver Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 45. Europe Liver Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Europe Liver Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Europe Liver Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 48. China Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 49. China Liver Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 50. China Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 51. China Liver Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 52. Asia Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 53. Asia Liver Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 54. Asia Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 55. Asia Liver Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 56. Asia Liver Cancer Diagnostics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 57. Asia Liver Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 58. Asia Liver Cancer Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Type (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Application (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Liver Cancer Diagnostics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 66. Abbott Laboratories Company Details
Table 67. Abbott Laboratories Business Overview
Table 68. Abbott Laboratories Liver Cancer Diagnostics Product
Table 69. Abbott Laboratories Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 70. Abbott Laboratories Recent Developments
Table 71. BD Company Details
Table 72. BD Business Overview
Table 73. BD Liver Cancer Diagnostics Product
Table 74. BD Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 75. BD Recent Developments
Table 76. Roche Holding AG Company Details
Table 77. Roche Holding AG Business Overview
Table 78. Roche Holding AG Liver Cancer Diagnostics Product
Table 79. Roche Holding AG Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 80. Roche Holding AG Recent Developments
Table 81. Fujifilm Healthcare Company Details
Table 82. Fujifilm Healthcare Business Overview
Table 83. Fujifilm Healthcare Liver Cancer Diagnostics Product
Table 84. Fujifilm Healthcare Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 85. Fujifilm Healthcare Recent Developments
Table 86. Hologic Company Details
Table 87. Hologic Business Overview
Table 88. Hologic Liver Cancer Diagnostics Product
Table 89. Hologic Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 90. Hologic Recent Developments
Table 91. Illumina Company Details
Table 92. Illumina Business Overview
Table 93. Illumina Liver Cancer Diagnostics Product
Table 94. Illumina Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 95. Illumina Recent Developments
Table 96. Philips Company Details
Table 97. Philips Business Overview
Table 98. Philips Liver Cancer Diagnostics Product
Table 99. Philips Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 100. Philips Recent Developments
Table 101. Oncimmune Company Details
Table 102. Oncimmune Business Overview
Table 103. Oncimmune Liver Cancer Diagnostics Product
Table 104. Oncimmune Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 105. Oncimmune Recent Developments
Table 106. Qiagen Company Details
Table 107. Qiagen Business Overview
Table 108. Qiagen Liver Cancer Diagnostics Product
Table 109. Qiagen Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 110. Qiagen Recent Developments
Table 111. Siemens Healthineers Company Details
Table 112. Siemens Healthineers Business Overview
Table 113. Siemens Healthineers Liver Cancer Diagnostics Product
Table 114. Siemens Healthineers Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 115. Siemens Healthineers Recent Developments
Table 116. Sirtex Medical Company Details
Table 117. Sirtex Medical Business Overview
Table 118. Sirtex Medical Liver Cancer Diagnostics Product
Table 119. Sirtex Medical Revenue in Liver Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 120. Sirtex Medical Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Liver Cancer Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Liver Cancer Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. Biopsy Features
Figure 4. Endoscopy Features
Figure 5. Laboratory Tests Features
Figure 6. Imaging Features
Figure 7. Others Features
Figure 8. Global Liver Cancer Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Liver Cancer Diagnostics Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Laboratory Case Studies
Figure 13. Liver Cancer Diagnostics Report Years Considered
Figure 14. Global Liver Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Liver Cancer Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Liver Cancer Diagnostics Market Share by Region: 2022 VS 2029
Figure 17. Global Liver Cancer Diagnostics Market Share by Players in 2022
Figure 18. Global Top Liver Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Diagnostics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Liver Cancer Diagnostics Revenue in 2022
Figure 20. North America Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Liver Cancer Diagnostics Market Share by Type (2018-2029)
Figure 22. North America Liver Cancer Diagnostics Market Share by Application (2018-2029)
Figure 23. North America Liver Cancer Diagnostics Market Share by Country (2018-2029)
Figure 24. United States Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Liver Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Liver Cancer Diagnostics Market Share by Type (2018-2029)
Figure 28. Europe Liver Cancer Diagnostics Market Share by Application (2018-2029)
Figure 29. Europe Liver Cancer Diagnostics Market Share by Country (2018-2029)
Figure 30. Germany Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Liver Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Liver Cancer Diagnostics Market Share by Type (2018-2029)
Figure 38. China Liver Cancer Diagnostics Market Share by Application (2018-2029)
Figure 39. Asia Liver Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Liver Cancer Diagnostics Market Share by Type (2018-2029)
Figure 41. Asia Liver Cancer Diagnostics Market Share by Application (2018-2029)
Figure 42. Asia Liver Cancer Diagnostics Market Share by Region (2018-2029)
Figure 43. Japan Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Share by Country (2018-2029)
Figure 53. Brazil Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Abbott Laboratories Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 60. BD Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 61. Roche Holding AG Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 62. Fujifilm Healthcare Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 63. Hologic Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 64. Illumina Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 65. Philips Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 66. Oncimmune Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 67. Qiagen Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 68. Siemens Healthineers Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 69. Sirtex Medical Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
Figure 1. Global Liver Cancer Diagnostics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Liver Cancer Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. Biopsy Features
Figure 4. Endoscopy Features
Figure 5. Laboratory Tests Features
Figure 6. Imaging Features
Figure 7. Others Features
Figure 8. Global Liver Cancer Diagnostics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Liver Cancer Diagnostics Market Share by Application: 2022 VS 2029
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Laboratory Case Studies
Figure 13. Liver Cancer Diagnostics Report Years Considered
Figure 14. Global Liver Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Liver Cancer Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Liver Cancer Diagnostics Market Share by Region: 2022 VS 2029
Figure 17. Global Liver Cancer Diagnostics Market Share by Players in 2022
Figure 18. Global Top Liver Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Cancer Diagnostics as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Liver Cancer Diagnostics Revenue in 2022
Figure 20. North America Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Liver Cancer Diagnostics Market Share by Type (2018-2029)
Figure 22. North America Liver Cancer Diagnostics Market Share by Application (2018-2029)
Figure 23. North America Liver Cancer Diagnostics Market Share by Country (2018-2029)
Figure 24. United States Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Liver Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Liver Cancer Diagnostics Market Share by Type (2018-2029)
Figure 28. Europe Liver Cancer Diagnostics Market Share by Application (2018-2029)
Figure 29. Europe Liver Cancer Diagnostics Market Share by Country (2018-2029)
Figure 30. Germany Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Liver Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Liver Cancer Diagnostics Market Share by Type (2018-2029)
Figure 38. China Liver Cancer Diagnostics Market Share by Application (2018-2029)
Figure 39. Asia Liver Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Liver Cancer Diagnostics Market Share by Type (2018-2029)
Figure 41. Asia Liver Cancer Diagnostics Market Share by Application (2018-2029)
Figure 42. Asia Liver Cancer Diagnostics Market Share by Region (2018-2029)
Figure 43. Japan Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Liver Cancer Diagnostics Market Share by Country (2018-2029)
Figure 53. Brazil Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Liver Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Abbott Laboratories Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 60. BD Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 61. Roche Holding AG Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 62. Fujifilm Healthcare Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 63. Hologic Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 64. Illumina Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 65. Philips Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 66. Oncimmune Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 67. Qiagen Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 68. Siemens Healthineers Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 69. Sirtex Medical Revenue Growth Rate in Liver Cancer Diagnostics Business (2018-2023)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
